Register >> Thursday, May 8, 2025 | 12:00-1:00PM EST As drug development becomes more complex and personalized, traditional randomized controlled trials (RCTs) are no longer sufficient to answer every research question—particularly in rare diseases, and situations lacking head-to-head comparisons. Regulators, payers and other stakeholders are increasingly turning to real-world evidence (RWE) to address the gaps,[…]
FiercePharma Register >> April 8, 2025 1:00PM – 2:00PM EST Traditional commercial strategies focus on known patient populations— but what about patients who aren’t on the radar? AI-powered digital phenotyping and real-world data (RWD) offer new ways to locate overlooked patient populations, identify gaps between clinical guidelines and real-world treatment patterns, and optimize market positioning[…]
Register >> Friday, January 10th 2025 10:00 – 11:00 AM EST Webinar Synopsis Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. This ambitious initiative aims to enroll 25,000 patients across diverse backgrounds to evaluate the clinical impact of Multi-Cancer Early Detection[…]
December 5, 2024 1:00 – 2:00pm ET Register >> In today’s complex healthcare landscape, going beyond traditional data is essential. Join our exclusive webinar to discover how scaling qualitative data from clinical notes, combined with AI, can reveal hidden patterns in patient journeys and treatment drivers, giving you a complete view of your therapy’s impact. Explore[…]
Tuesday, November 19, 2024 2:00-3:00PM ET Register >> Clinical trial recruitment remains a major bottleneck for the pharmaceutical industry, with 85% of trials struggling to meet participant targets despite nearly $1.9 billion spent annually. The financial stakes are high, with trial delays, primarily due to patient recruitment costing companies between $600K to $8M per day.[…]
